Utilizing growth factors and cytokines to boost dendritic cell proliferation and differentiation

日本 ニュース ニュース

Utilizing growth factors and cytokines to boost dendritic cell proliferation and differentiation
日本 最新ニュース,日本 見出し
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 71%

This article explores growth factors and cytokines to boost dendritic cell proliferation and differentiation.

Sponsored Content by ACROBiosystemsApr 2 2024Reviewed by Aimee Molineux Dendritic cells are exceptionally potent antigen-presenting cells in the human body and are considered the “sentinels” of the immune system. They are essential in establishing, maintaining, and strengthening innate and adaptive immune responses. They interact with various immune cells like T and B cells, increasing the efficacy of immune responses.

DC cell therapy: An ex vivo approach for DC vaccination In this method, monocytes are first isolated from the patient's blood, or CD34+ precursor cells are collected from the bone marrow. Cells are then stimulated and differentiated using a variety of cytokines, prompting the creation of immature dendritic cells . These immature DCs are filled with antigens, including nucleic acids to peptides, proteins, cells, or nanoparticles, using methods like cell fusion, co-culture, or transfection.

However, growth factors, including TNF-α, IFN-β, IFN-γ, IL-6, and PGE2, are required to prompt differentiation into mature CD1a+CD83+ DCs for use in the following cell therapy production processes. In addition, DCVax-L has shown promise for treating glioblastoma in Germany. These vaccines use a patient's DCs, filled with tumor antigens, to provoke an immune response against cancer.

Research in the last two decades on DC vaccines/cell therapy has taken extraordinary steps in improving the migratory abilities and immune effectiveness of DCs.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

NewsMedical /  🏆 19. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Advancements in CAR-T Therapy: Utilizing Antigen Multimers for Improved Workflow AutomationAdvancements in CAR-T Therapy: Utilizing Antigen Multimers for Improved Workflow AutomationThe ability to engineer immune cells is at the leading edge of cancer treatment. CAR-T therapy has effectively treated relapsed or refractory hematological malignancies. CAR-T's continued growth has created a requirement for CAR cell-related reagents and tools. Antigen multimers, such as pre-coupled magnetic multimers, are precise and accurate in CAR cell activation, detection, expansion, enrichment, and ex vivo analysis.
続きを読む »

Why is Particle Size Analysis Important?Why is Particle Size Analysis Important?Advancements in particle size analysis enhance quality control across industries, utilizing AI and smartphone photogrammetry for improved accuracy.
続きを読む »

Man Utd: Ratcliffe identifies ‘de facto kingmaker’ on Ten Hag future as INEOS get Ashworth boostMan Utd: Ratcliffe identifies ‘de facto kingmaker’ on Ten Hag future as INEOS get Ashworth boostNew Man Utd co-owner Sir Jim Ratcliffe 'will task' incoming CEO Omar Berrada 'with deciding possible' managerial change, according to reports.
続きを読む »

De facto independence referendum strategy has one significant flawALAN Crockett (Long Letter, Apr 1) suggests that the SNP should use the forthcoming UK General Election as a plebiscite for independence. Many…
続きを読む »

Millions of UK households to get £3,082 boost from April 1Millions of UK households to get £3,082 boost from April 1The new 2024-25 tax year begins on April 1, which is why there are always so many significant financial changes at this time of year
続きを読む »

Seven ways to boost your mood – which are free and take no effortSeven ways to boost your mood – which are free and take no effortFrom sharing secrets to watching the sunrise, experts give their input on becoming happier (for no extra cost)
続きを読む »



Render Time: 2025-04-02 13:35:57